Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 122.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.10% |
| Dec 31, 2025 | 15.63% |
| Sep 30, 2025 | 132.81% |
| Jun 30, 2025 | 38.82% |
| Mar 31, 2025 | 27.57% |
| Dec 31, 2024 | 37.57% |
| Sep 30, 2024 | 27.00% |
| Jun 30, 2024 | 8.19% |
| Mar 31, 2024 | 60.36% |
| Dec 31, 2023 | 91.85% |
| Sep 30, 2023 | 73.50% |
| Jun 30, 2023 | 72.83% |
| Mar 31, 2023 | 87.89% |
| Dec 31, 2022 | 79.63% |
| Sep 30, 2022 | 69.75% |
| Jun 30, 2022 | 54.04% |
| Mar 31, 2022 | -5.27% |
| Dec 31, 2021 | 26.22% |
| Mar 31, 2021 | 49.97% |
| Dec 31, 2020 | -403.17% |